NCT04671615View on ClinicalTrials.gov

A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel.

CompletedOBSERVATIONAL
Enrollment

559

Participants

Timeline

Start Date

December 6, 2020

Primary Completion Date

October 6, 2021

Study Completion Date

January 1, 2023

Conditions
Metastatic Breast Cancer
Interventions
DRUG

palbociclib

As provided in real world practice

Trial Locations (1)

4672509

Pfizer Pharmaceuticals Israel Ltd., Herzliya Pituah

Sponsors

Lead Sponsor

Pfizer
All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04671615 - A Study to Understand the Treatment Patterns and Patients and Their Clinical Outcomes Who Are Taking Palbociclib in a Real Life Setting in Israel. | Biotech Hunter | Biotech Hunter